Ozempic, junto con otros medicamentos como Wegovy y Rybelsus, ha transformado el tratamiento de la obesidad y diabetes tipo 2, al punto que la revista Science lo nombr como el avance cientfico de 2023
Consistency is the key to seeing long-term benefits
Prolonged therapeutic benefits In a study conducted by Hsieh et al
All these risk factors have a common characteristic, they are associated with a continuous state of oxidative stress and inflammation, excessive production of free radicals (reactive oxygen and nitrogen species) and endothelial cell dysfunction leading to cardiovascular disease and respiratory failure
The side effects of Mounjaro are usually mild to moderate
Clinical trials continue confirming its unforeseen potential in cardiovascular, kidney and liver diseases research that reinforces Thomass evolving perspective: I used to be sceptical about treating obesity with medicine, but Im now convinced that its both meaningful and necessary, he says
